Related Experiment Video
Updated: Aug 7, 2026

A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
In vitro activity of grepafloxacin and 25 other antimicrobial agents against Streptococcus pneumoniae: correlation
C Thornsberry1, P T Ogilvie, H P Holley
1MRL Pharmaceutical Services, Brentwood, Tennessee 37027, USA.
Abstract:
Strains of Streptococcus pneumoniae from the United States that were susceptible, intermediately resistant, or highly resistant to penicillin were tested for susceptibility to 26 antimicrobial agents that have been used or considered for the treatment of patients with pneumococcal infections. The drugs tested included penicillins, one penicillin/beta-lactamase inhibitor combination, cephalosporins, macrolides, a lincosamide, fluoroquinolones, and four miscellaneous drugs (vancomycin, rifampin, tetracycline, and trimethoprim-sulfamethoxazole). The activities of the penicillins and macrolide agents were similar, but the activities within the cephalosporin and fluoroquinolone classes were often dissimilar. For the fluoroquinolones, the order of in vitro activity, from most to least active, was grepafloxacin, sparfloxacin, levofloxacin, ciprofloxacin, and ofloxacin. Increased resistance to penicillin in the pneumococcal isolates studied correlated with increased resistance to other penicillins, cephalosporins, macrolides, clindamycin, tetracycline, and trimethoprim-sulfamethoxazole but did not correlate with increased resistance to the fluoroquinolones, rifampin, or vancomycin. These findings may be helpful to health professionals selecting empiric therapy for respiratory tract infections involving S. pneumoniae.
Insights
Penicillin resistance in Streptococcus pneumoniae strains correlates with resistance to many antibiotics, but not fluoroquinolones, rifampin, or vancomycin. This guides empiric therapy selection for pneumococcal infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Streptococcus pneumoniae is a leading cause of bacterial infections.
- Antimicrobial resistance in S. pneumoniae poses a significant public health challenge.
- Understanding resistance patterns is crucial for effective treatment.
Purpose of the Study:
- To evaluate the in vitro susceptibility of S. pneumoniae strains to various antimicrobial agents.
- To determine the correlation between penicillin resistance and resistance to other drug classes.
- To inform empiric therapy choices for pneumococcal infections.
Main Methods:
- Testing susceptibility of U.S. S. pneumoniae isolates (susceptible, intermediate, high penicillin resistance) to 26 antimicrobial agents.
- Classifying agents into penicillins, cephalosporins, macrolides, fluoroquinolones, etc.
- Analyzing correlations between penicillin resistance and resistance to other agents.
Main Results:
- Penicillin and macrolide activities were similar; cephalosporin and fluoroquinolone activities varied.
- Fluoroquinolone activity order: grepafloxacin > sparfloxacin > levofloxacin > ciprofloxacin > ofloxacin.
- Penicillin resistance correlated with resistance to penicillins, cephalosporins, macrolides, clindamycin, tetracycline, and trimethoprim-sulfamethoxazole.
Conclusions:
- Penicillin resistance in S. pneumoniae is linked to resistance to several key antibiotic classes.
- Resistance to fluoroquinolones, rifampin, and vancomycin did not correlate with penicillin resistance.
- Findings aid clinicians in selecting appropriate empiric treatment for S. pneumoniae infections.
More Related Videos
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Antimicrobial Effectiveness
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance